foropafant has been researched along with rupatadine in 1 studies
| Studies (foropafant) | Trials (foropafant) | Recent Studies (post-2010) (foropafant) | Studies (rupatadine) | Trials (rupatadine) | Recent Studies (post-2010) (rupatadine) |
|---|---|---|---|---|---|
| 37 | 4 | 1 | 116 | 43 | 62 |
| Protein | Taxonomy | foropafant (IC50) | rupatadine (IC50) |
|---|---|---|---|
| Platelet-activating factor receptor | Homo sapiens (human) | 3.7 | |
| Histamine H1 receptor | Homo sapiens (human) | 0.0039 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brazís, P; de Mora, F; Merlos, M; Puigdemont, A; Queralt, M | 1 |
1 other study(ies) available for foropafant and rupatadine
| Article | Year |
|---|---|
In vitro inhibitory effect of rupatadine on histamine and TNF-alpha release from dispersed canine skin mast cells and the human mast cell line HMC-1.
Topics: Animals; Antibodies; Calcimycin; Cell Line; Concanavalin A; Cyproheptadine; Dogs; Histamine Antagonists; Histamine Release; Humans; Immunoglobulin E; Loratadine; Mast Cells; Skin; Thiazoles; Tumor Necrosis Factor-alpha | 2000 |